Tangram Therapeutics
Generated by Meeveem AI
"Uniting computation, RNAi, and unconventional thinking to accelerate genetic medicine discovery"
London
•11 - 50 Employees
•Biotechnology
About Tangram Therapeutics
Tangram Therapeutics integrates computational power and biology to accelerate the discovery of RNA interference medicines. The company harnesses AI and extensive biological data to identify unexplored disease targets with strong genetic evidence, pursuing opportunities others miss through a relentless, data-driven approach. By uniting unconventional thinking with proprietary technologies like LLibra and GalOmic, Tangram reduces the risk of clinical failure and expedites the path from discovery to real-world impact. Its focus is on creating genetic medicines that work faster, with higher probability of success, transforming lives within our lifetime.
30
Team Members
2001
Founded
Biotechnology
Sector
Hybrid
Work Environment
Our Vision
A world where computational drug discovery powered by robust biological data makes genetic medicines that transform lives within our lifetime a reality.
Our Mission
Tangram integrates computational power and biology to accelerate the discovery of life-transforming RNAi medicines by identifying and pursuing unexplored targets backed by robust biological data.